Table 6.

Test re‐test reproducibility of pRNFL OCT measurements.

	MS group			Reference group
	All patients with MS N = 656	Patients without MS‐ON1 N = 537	Patients with MS‐ON N = 119	Healthy participants N = 122
n	642	524	118	121
Baseline, (µm)	88.84 ± 15.35	91.52 ± 13.89	76.86 ± 15.87	100.45 ± 9.15
Month 1, (µm)	88.96 ± 15.41	91.64 ± 14.01	77.03 ± 15.78	100.13 ± 9.34
Difference, (µm)	0.12 ± 1.82	0.14 ± 1.86	0.01 ± 1.60	−0.35 ± 1.73
95% CI for mean	(−0.02, 0.26)	(−0.02, 0.30)	(−0.28, 0.30)	(−0.66, −0.04)
p‐value	0.1036	0.0840	0.9429	0.0271
ICC (95% CI)	0.993 (0.992, 0.994)	0.991 (0.989, 0.992)	0.995 (0.993, 0.996)	0.982 (0.974, 0.987)

Values are mean ± SD unless otherwise indicated

CI, confidence interval; ICC, intraclass correlation coefficient; MS, multiple sclerosis; MS‐ON; multiple sclerosis‐associated optic neuritis; N is the total number of eyes in the analysis population, n is the number of eyes with data available.

¹Without previous MS‐ON